250 related articles for article (PubMed ID: 24579311)
1. [Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP].
Men T; Piao SH; Teng CB
Yi Chuan; 2013 Nov; 35(11):1283-90. PubMed ID: 24579311
[TBL] [Abstract][Full Text] [Related]
2. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
3. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
Kim M; Kim T; Johnson RL; Lim DS
Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
[TBL] [Abstract][Full Text] [Related]
5. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
[TBL] [Abstract][Full Text] [Related]
6. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
[TBL] [Abstract][Full Text] [Related]
8. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
[TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ regulate skin wound healing.
Lee MJ; Byun MR; Furutani-Seiki M; Hong JH; Jung HS
J Invest Dermatol; 2014 Feb; 134(2):518-525. PubMed ID: 24108406
[TBL] [Abstract][Full Text] [Related]
10. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
12. Label-free quantitative proteomic analysis of the YAP/TAZ interactome.
Kohli P; Bartram MP; Habbig S; Pahmeyer C; Lamkemeyer T; Benzing T; Schermer B; Rinschen MM
Am J Physiol Cell Physiol; 2014 May; 306(9):C805-18. PubMed ID: 24573087
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells.
Karystinou A; Roelofs AJ; Neve A; Cantatore FP; Wackerhage H; De Bari C
Arthritis Res Ther; 2015 May; 17(1):147. PubMed ID: 26025096
[TBL] [Abstract][Full Text] [Related]
14. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
15. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
[TBL] [Abstract][Full Text] [Related]
16. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
17. An overview of signaling pathways regulating YAP/TAZ activity.
Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X
Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
[TBL] [Abstract][Full Text] [Related]
19. PPARĪ³ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity.
Basu-Roy U; Han E; Rattanakorn K; Gadi A; Verma N; Maurizi G; Gunaratne PH; Coarfa C; Kennedy OD; Garabedian MJ; Basilico C; Mansukhani A
Oncotarget; 2016 Sep; 7(38):60954-60970. PubMed ID: 27528232
[TBL] [Abstract][Full Text] [Related]
20. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
